117 related articles for article (PubMed ID: 2401092)
1. Return of ovarian function following spontaneous abortion.
Donnet ML; Howie PW; Marnie M; Cooper W; Lewis M
Clin Endocrinol (Oxf); 1990 Jul; 33(1):13-20. PubMed ID: 2401092
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
3. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
Branch CM; Collins PO; Kilpatrick MJ; Collins WP
Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
[TBL] [Abstract][Full Text] [Related]
4. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
6. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
Cameron IT; Baird DT
Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
[TBL] [Abstract][Full Text] [Related]
7. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
8. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
10. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
11. Side of ovulation and cycle characteristics in normally fertile women.
Ecochard R; Gougeon A
Hum Reprod; 2000 Apr; 15(4):752-5. PubMed ID: 10739814
[TBL] [Abstract][Full Text] [Related]
12. Return of ovarian function after abortion.
Lähteenmäki P; Luukkainen T
Clin Endocrinol (Oxf); 1978 Feb; 8(2):123-32. PubMed ID: 630723
[TBL] [Abstract][Full Text] [Related]
13. Effects of early pregnancy loss on hormone levels in the subsequent menstrual cycle.
Jukic AM; Weinberg CR; Wilcox AJ; Baird DD
Gynecol Endocrinol; 2010 Dec; 26(12):897-901. PubMed ID: 20504096
[TBL] [Abstract][Full Text] [Related]
14. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
15. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
16. Urinary hormone levels at the time of ovulation and implantation.
Lasley BL; Stabenfeldt GH; Overstreet JW; Hanson FW; Czekala N; Munro C
Fertil Steril; 1985 Jun; 43(6):861-7. PubMed ID: 3996630
[TBL] [Abstract][Full Text] [Related]
17. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
[TBL] [Abstract][Full Text] [Related]
18. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
19. Validation of the dual analyte assay of the oestrone:pregnanediol ratio in monitoring ovarian function.
Fabres C; Zegers-Hochschild F; Altieri E; Llados C
Hum Reprod; 1993 Feb; 8(2):208-10. PubMed ID: 8473420
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia.
Bath LE; Anderson RA; Critchley HO; Kelnar CJ; Wallace WH
Hum Reprod; 2001 Sep; 16(9):1838-44. PubMed ID: 11527885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]